Trimethoprim-sulfamethoxazole for skin and soft tissue infections--let us not forget the risks.
Department of Medicine, Division of Infectious Diseases, Denver Health and Hospital Authority, Denver, CO; Department of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO.
Timothy C
TC
Jenkins
Department of Medicine, Division of Infectious Diseases, Denver Health and Hospital Authority, Denver, CO; Department of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO.
Michelle K
MK
Haas
Department of Pharmacy, Denver Health and Hospital Authority, Denver, CO; University of Colorado School of Pharmacy, Aurora, CO.
Katherine C
KC
Shihadeh
Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, Denver, CO; Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO.
Eric J
EJ
Lavonas
D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced; D012307:Risk Factors; D017192:Skin Diseases, Bacterial / Q000188:drug therapy*; D018461:Soft Tissue Infections / Q000188:drug therapy*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects* / Q000627:therapeutic use
D000890:Anti-Infective Agents; D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination